A Phase III, Multicenter, Parallel-Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam Versus Vehicle in Women With Female Pattern Hair Loss
用户ZZBdUadOS9nM
1个月前
92
10
已完结
1. 系统已在2026-04-21 13:50:28对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://pubmed.ncbi.nlm.nih.gov/27391639
其他信息:
PMID: 27391639
作者: Wilma Bergfeld; Ken Washenik; Valerie Callender; Paul Zhang; Carlos Quiza; ...
摘要: BACKGROUND Female pattern hair loss (FPHL) is a common hair disorder that affects millions of women. A new 5% minoxidil topical foam (MTF) formulation, which does not contain propylene glycol, has been developed.<br/>
